...
首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Interventional catheterization for congenital heart defects: what can we do for others? Project Rwanda
【24h】

Interventional catheterization for congenital heart defects: what can we do for others? Project Rwanda

机译:先天性心脏缺陷的介入导尿:我们能为他人做些什么?卢旺达项目

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Interventional catheterization has nowadays become the method of choice in treatment of several congenital heart defects (CHD). It is also developing quickly in Poland. The number of transcatheter procedures reached a similar number to cardiac surgery procedures in CHD in 2018 (2293 vs. 2271) [1]. Our interest in international collaboration and development of interventional cardiology in CHD has been evolving for many years. Recently, we were awarded by the Polish Cardiac Society for 24 articles published in the years 2012–2017 [2]. In 2007 we started in our centre an educational programme for young interventional CHD cardiologists from different countries. Since then, we have trained 23 cardiologists (all below 40 years old) from different countries in Europe (Ukraine, Belarus, Bulgaria, Georgia, Italy, Russia), Latin America (Mexico, Colombia, Bolivia, Guatemala, Argentina), Asia (Uzbekistan, China) and Africa (Rwanda). The training period varied from 1 to 12 months. A Letter to the Editor titled ‘Percutaneous treatment of CHD, what was new in 2014’ was recently published in Kardiologia Polska [3], describing, among other topics, my idea of a mobile cath-lab laboratory mounted on a truck for Africa needs. Despite the fact that we received support from a key person of the World Health Organization (WHO) and the Vatican, unfortunately, the latter project has not developed further. Also interest showed by African paediatric cardiologists in this idea (presented by me) during the CSI Africa Congress in Addis Ababa in December 2014 and the CSI in Frankfurt (main congress) in June 2015 was moderate. I have started to think that something is wrong and that the idea might be too general and I should change the strategy [4]. The next step was my “tourist” visit to Rwanda in 2018 and fellowship of Dr Yves Mutabandama in 2019 in our centre (Silesian Centre for Heart Diseases, Zabrze). He is well educated, finishing his paediatric cardiology training at Kigali Teaching University in Rwanda. Rwanda is a small African, equatorial country. It has only 26 000 square km and a population of 12.5 million habitants (60% children) with a stormy contemporary history. However, now it has become a politically and economically stable country. As in many other Central and Eastern Africa countries, there are no regular cardiac catheterizations laboratories. In Rwanda some simples percutaneous interventions in CHD were performed only during a few missions...
机译:如今,介入导管术已成为治疗几种先天性心脏缺陷(CHD)的一种选择方法。它在波兰也正在迅速发展。 2018年,经导管手术的数量达到了冠心病心脏外科手术的数量(2293比2271)[1]。多年来,我们对国际合作和冠心病介入性心脏病学发展的兴趣一直在发展。最近,我们被波兰心脏学会授予2012-2017年发表的24篇文章[2]。 2007年,我们在中心开始了一项针对来自不同国家的年轻介入性CHD心脏病专家的教育计划。从那时起,我们已经培训了来自欧洲(乌克兰,白俄罗斯,保加利亚,乔治亚州,意大利,俄罗斯),拉丁美洲(墨西哥,哥伦比亚,玻利维亚,危地马拉,阿根廷),欧洲(乌克兰,白俄罗斯,保加利亚,格鲁吉亚,危地马拉,阿根廷)的23位心脏病专家(年龄均在40岁以下)乌兹别克斯坦,中国)和非洲(卢旺达)。培训时间从1到12个月不等。最近在Kardiologia Polska [3]上发表了一封给编辑的信,标题为“经皮冠心病经皮治疗,2014年的新功能”,其中描述了我关于在非洲卡车上安装移动式实验室实验室的想法以及其他主题。 。尽管我们得到了世界卫生组织(WHO)和梵蒂冈的关键人物的支持,但不幸的是,后者的项目并没有得到进一步发展。 2014年12月在亚的斯亚贝巴举行的CSI非洲大会和2015年6月在法兰克福的CSI(主要大会)期间,非洲儿科心脏病学家对这一想法(由我提出)也表现出了兴趣。我开始认为出了点问题,想法可能太笼统了,我应该改变策略[4]。下一步是我于2018年对卢旺达的“游客”访问,并于2019年在我们的中心(扎布热西里西亚心脏病中心)的伊夫·穆塔班达玛博士(Yves Mutabandama)进修。他受过良好的教育,在卢旺达的基加利教学大学完成了小儿心脏病学培训。卢旺达是非洲的赤道小国。它只有26000平方公里,人口为1250万,风风雨雨的当代历史使居民(60%的儿童)受益。但是,现在它已成为一个政治和经济稳定的国家。与许多其他中非和东非国家一样,没有定期的心脏导管检查实验室。在卢旺达,仅在几次任务中对冠心病进行了一些简单的经皮介入治疗...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号